» Articles » PMID: 33110611

Recommendations for the Adjuvant Use of the Poly-antibiotic-resistant Probiotic (O/C, SIN, N/R, T) in Acute, Chronic, and Antibiotic-associated Diarrhea in Children: Consensus from Asian Experts

Abstract

This paper proposes recommendations for probiotics in pediatric gastrointestinal diseases in the Asia-Pacific region. Evidence-based recommendations and randomized controlled trials in the region are included. Cultural aspects, health management issues and economic factors were also considered. Final recommendations were approved by utilizing a modified Delphi process and applying the Likert scale in an electronic voting process. was recommended as an adjunct treatment with oral rehydration solution for acute viral diarrhea. may also be considered for prevention of antibiotic-associated diarrhea, -induced diarrhea, and as adjunct treatment of There is insufficient evidence for recommendations in other conditions. Despite a diversity of epidemiological, socioeconomical and health system conditions, similar recommendations currently apply to most Asia-Pacific countries. Ideally, these need to be validated with local randomized-controlled trials.

Citing Articles

Effect of the Probiotic DE-CA9 on Fecal Scores, Serum Oxidative Stress Markers and Fecal and Serum Metabolome in Healthy Dogs.

Allenspach K, Sung C, Ceron J, Rubio C, Bourgois-Mochel A, Suchodolski J Vet Sci. 2023; 10(9).

PMID: 37756088 PMC: 10537710. DOI: 10.3390/vetsci10090566.


HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains.

Calvigioni M, Bertolini A, Codini S, Mazzantini D, Panattoni A, Massimino M Front Microbiol. 2023; 14:1124144.

PMID: 36937254 PMC: 10020375. DOI: 10.3389/fmicb.2023.1124144.


Effect of P9 on defecation, quality of life and gut microbiome in individuals with chronic diarrhoea: Protocol for a randomized, double-blind, placebo-controlled clinical trial.

Liu W, Lu N, Zhou X, Li Y, Xie Y, Zheng L Contemp Clin Trials Commun. 2023; 32:101085.

PMID: 36865679 PMC: 9970898. DOI: 10.1016/j.conctc.2023.101085.


Current understanding of antibiotic-associated dysbiosis and approaches for its management.

Kesavelu D, Jog P Ther Adv Infect Dis. 2023; 10:20499361231154443.

PMID: 36860273 PMC: 9969474. DOI: 10.1177/20499361231154443.


Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.

Acosta-Rodriguez-Bueno C, Abreu Y Abreu A, Guarner F, Guno M, Pehlivanoglu E, Perez 3rd M Adv Ther. 2022; 39(11):4854-4874.

PMID: 36018495 PMC: 9525334. DOI: 10.1007/s12325-022-02285-0.


References
1.
Szajewska H, Kolodziej M . Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015; 42(7):793-801. DOI: 10.1111/apt.13344. View

2.
Shen N, Maw A, Tmanova L, Pino A, Ancy K, Crawford C . Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. Gastroenterology. 2017; 152(8):1889-1900.e9. DOI: 10.1053/j.gastro.2017.02.003. View

3.
Ianiro G, Rizzatti G, Plomer M, Lopetuso L, Scaldaferri F, Franceschi F . for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018; 10(8). PMC: 6116021. DOI: 10.3390/nu10081074. View

4.
Nista E, Candelli M, Cremonini F, Cazzato I, Zocco M, Franceschi F . Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004; 20(10):1181-8. DOI: 10.1111/j.1365-2036.2004.02274.x. View

5.
Gwee K, Lee W, Ling K, Ooi C, Quak S, Dan Y . Consensus and contentious statements on the use of probiotics in clinical practice: A south east Asian gastro-neuro motility association working team report. J Gastroenterol Hepatol. 2018; 33(10):1707-1716. DOI: 10.1111/jgh.14268. View